检验医学 ›› 2025, Vol. 40 ›› Issue (4): 338-343.DOI: 10.3969/j.issn.1673-8640.2025.04.005

• 肝癌新标志物基础研究和临床应用专题 • 上一篇    下一篇

ZBED3、CYFRA21-1和VEGF与肝癌晚期患者短期死亡风险的相关性

陈威龙, 王永兵, 陈泽刚   

  1. 重庆市梁平区人民医院肿瘤科,重庆 405200
  • 收稿日期:2024-03-31 修回日期:2025-01-17 出版日期:2025-04-30 发布日期:2025-05-08
  • 作者简介:陈威龙,男,1980年生,学士,副主任医师,主要从事肿瘤诊治工作。

Correlation between ZBED3,CYFRA21-1,VEGF and short-term mortality risk in patients with advanced liver cancer

CHEN Weilong, WANG Yongbing, CHEN Zegang   

  1. Department of Oncology,Liangping District People's Hospital,Chongqing 405200,China
  • Received:2024-03-31 Revised:2025-01-17 Online:2025-04-30 Published:2025-05-08

摘要:

目的 探讨含BED型锌指蛋白3(ZBED3)、细胞角蛋白19片段(CYFRA21-1)、血管内皮生长因子(VEGF)在肝癌晚期患者死亡风险评估中的价值。方法 选取2020年1月—2022年12月重庆市梁平区人民医院肝癌晚期患者99例。收集所有研究对象的临床资料,并检测ZBED3、CYFRA21-1、VEGF、甲胎蛋白(AFP)、异常凝血酶原(PIVKAⅡ)、白细胞(WBC)计数,计算中性粒细胞/淋巴细胞比值(NLR)。对所有患者随访180 d,根据是否死亡分为死亡组(35例)和存活组(64例)。采用Spearman相关分析评估各项指标之间的相关性。采用受试者工作特征(ROC)曲线评价各项指标判断肝癌晚期患者短期死亡的效能。采用Kaplan-Meier生存曲线分析肝癌晚期患者的生存情况。采用Cox回归分析评估肝癌晚期患者短期死亡的影响因素。结果 死亡组CYFRA21-1、VEGF、ZBED3、AFP、PIVKAⅡ、WBC计数、NLR和Child-Pugh评分均高于存活组(P<0.001),其他指标2个组之间差异均无统计学意义(P>0.05)。肝癌晚期患者死亡与否与CYFRA21-1、VEGF、ZBED3、Child-Pugh评分、AFP、PIVKAⅡ、WBC计数、NLR均呈正相关(r值分别为0.609、0.364、0.760、0.759、0.651、0.639、0.527、0.728,P<0.05)。CYFRA21-1、ZBED3、Child-Pugh评分、VEGF、AFP、PIVKAⅡ、WBC计数、NLR判断肝癌晚期患者短期死亡的曲线下面积(AUC)分别为0.868、0.720、0.959、0.955、0.893、0.886、0.818、0.939。CYFRA21-1、VEGF、ZBED3高水平组存活率(26.5%、15.0%、3.3%)均分别低于低水平组(84.5%、77.2%、91.3%)(Log-rank χ2值分别为37.424、32.449、99.247,P<0.001)。AFP、WBC计数、ZBED3、Child-Pugh评分是HCC晚期患者短期死亡的危险因素[风险比(HR)值分别为1.008、1.946、1.013、1.237,95%可信区间(CI)分别为1.002~1.014、1.418~2.672、1.028~1.042、1.049~1.460,P<0.05]。结论 ZBED3、CYFRA21-1、VEGF与肝癌晚期患者短期死亡有关。ZBED3与传统指标AFP、WBC计数、Child-Pugh评分联合对肝癌晚期患者短期死亡风险有较高的预测价值。

关键词: 含BED型锌指蛋白3, 细胞角蛋白19片段, 血管内皮生长因子, 肝癌, 死亡风险

Abstract:

Objective To study the roles of zinc finger BED domain-containing protein 3(ZBED3),cytokeratin 19 fragment antigen 21-1(CYFRA21-1),vascular endothelial growth factor(VEGF) in risk assessment of advanced liver cancer patients.Methods A retrospective analysis was conducted on 99 patients with advanced liver cancer treated in Liangping District People's Hospital from January 2020 to December 2022. The clinical data were collected,and ZBED3,CYFRA21-1,VEGF,alpha-fetoprotein(AFP),protein induced by vitamin K absence or antagonist-Ⅱ(PIVKAⅡ) and white blood cell(WBC) count were determined. Neutrophil/lymphocyte ratio(NLR) was calculated. All the patients were followed up for 180 d and classified into death group(35 cases) and survival group(64 cases). Spearman correlation analysis was used to evaluate the correlation among the indicators. Receiver operating characteristic(ROC) curve was used to evaluate the efficacy of each indicator in determining short-term mortality in patients with advanced liver cancer. Kaplan-Meier survival curve was used to analyze the survival of patients with advanced liver cancer. Cox regression analysis was used to evaluate the influencing factors of mortality in patients with advanced liver cancer.Results CYFRA21-1,VEGF,ZBED3,AFP,PIVKAⅡ,WBC count,NLR and Child-Pugh score in death group were higher than those in survival group(P<0.001),and there was no statistical significance in the other indicators between the 2 groups(P>0.05). There were positive correlations between CYFRA21-1,VEGF,ZBED3,Child-Pugh score,AFP,PIVKAⅡ,WBC count and NLR(r values were 0.609,0.364,0.760,0.759,0.651,0.639,0.527 and 0.728,respectively,P<0.05). The areas under curves(AUC) of CYFRA21-1,ZBED3,Child-Pugh score,VEGF,AFP,PIVKAⅡ,WBC count and NLR were 0.868,0.720,0.959,0.955,0.893,0.886,0.818 and 0.939,respectively. The survival rate of high-level CYFRA21-1,VEGF and ZBED3 groups(26.5%,15.0% and 3.3%) were lower than those of low-level groups(84.5%,77.2% and 91.3%)(Log-rank χ2=37.424,32.449 and 99.247,P<0.001). AFP,WBC count,ZBED3 and Child-Pugh score were all risk factors for short-term mortality in advanced liver cancer patients [hazard ratios(HR) were 1.008,1.946,1.013 and 1.237,95% confidence intervals(CI)were 1.002-1.014,1.418-2.672,1.028-1.042 and 1.049-1.460,P<0.05].Conclusions ZBED3,CYFRA21-1 and VEGF are associated with mortality risk in patients with advanced liver cancer,and the combined determination of ZBED3,AFP,WBC count and Child-Pugh score has a high predictive value for the short-term mortality risk in patients with advanced liver cancer.

Key words: Zinc finger BED domain-containing protein 3, Cytokeratin 19 fragment antigen 21-1, Vascular endothelial growth factor, Liver cancer, Mortality risk

中图分类号: